- Rising global healthcare costs
- Supply chain disruptions
- Evolving consumer preferences
- Aging population with increased healthcare needs
- Staffing shortages
- Climate change impacts on healthcare
- Increased regulatory demands and customer expectations for ESG practices
- Need to increase supply chain transparency and ensure ethical sourcing data is near real-time and auditable
Medline Industries, LP
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Medline Industries, LP disclosed greenhouse gas emissions of 7.1M tCO2e. By scope: Scope 1: 173.8K tCO2e; Scope 2: 131.9K tCO2e; Scope 3: 7.0M tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
7.1M tCO2e
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 173.8K tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 131.9K tCO2e |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 7.0M tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 7.1M tCO2e |
| 2020 | 1.6K tonnes of CO2e |
| 2019 | 1.5K tCO2e (Scope 1 & 2) |
| 2018 | 305.6K MT CO2e (2017) |
| 2017 | 249.4K MT CO2e (2016) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Globalized GHG emissions data collection and expanded GHG calculations to include all categories of Scope 3 emissions
- Reached $34.5 million in total solar energy investments worldwide
- Added 37,162 solar panels in Medline’s renewable energy portfolio, including significant installations at our Montgomery, New York and Uxbridge, Massachusetts sites
- Invested in a carbon accounting platform to better serve our ESG efforts
- Completed product-level Life Cycle Assessments (LCA) for our European drapes and gowns following ISO 14040 methodology
- Reprocessed 2,564,389 medical devices through the Medline ReNewal program’s own facilities
- Diverted 1,518,654 pounds of landfill waste from the Medline ReNewal program, including both Medline and partner diversion efforts
- Doubled the size of our Medline ReNewal plant, increasing our capacity to reprocess medical devices
🌱 ESG Focus Areas
Climate resilience and environmental actionResponsible productsPeople and communitiesRobust governance